NERA Economic Consulting
ENTIRE SITE
NERA EXPERTS
EXPERTS
PRACTICE AREAS
ABOUT NERA |
Contact Us
About NERA
MMC Family
GLOBAL LOCATIONS |
CASE & PROJECT EXPERIENCE |
PUBLICATIONS |
Just Published
Newsletters & Briefs
Publications Search
EVENTS & NEWS |
Events
Speakers' Bureau
Continuing Legal Education
Press Releases
NERA in the News
Media Kit
CAREERS
Home
>
Practice Areas
>
Health Care and Life Sciences
> View All
|
More
< Go Back
All Publications for Health Care and Life Sciences
High Court Brings Economics Back To Pay-For-Delay Analysis
Published Article
2013-06-17
By Dr. Sumanth Addanki, Dr. Alan Daskin, and Dr. Christine Siegwarth Meyer
Switching Pharmaceutical Products from Prescription to Over-the-Counter: The Debate in the US
Published Article
2012-12-01
By Dr. Richard Rozek
Economics as a Guide to Developing Public Policies for Biosimilar Pharmaceutical Products
Published Article
2012-11-01
By Dr. Richard Rozek
An Inside Look at Monopsony Issues in the FTC's Express Scripts-Medco Merger Investigation
Published Article
2012-09-15
By John Scalf with Rani Habash of Dechert LLP
How Much Does that Medication Cost? A Study of Medicare Beneficiaries' Knowledge of Out-of-Pocket Costs for Prescription Drugs on the Specialty Tier
Study
2011-08-08
By Dr. Eugene Ericksen and Melissa Pittaoulis
An Economic Perspective on Small and Large Molecule Pharmaceutical Technologies (Una perspectiva economica sobre las tecnologias farmaceuticas de moleculas pequeñas y grandes)
Published Article
2011-08-01
By Dr. Richard Rozek
Risk and Regulatory Factors Affecting Location Decisions by Research-Based Pharmaceutical Companies
Published Article
2011-01-31
By Dr. Richard Rozek
An Analysis of Price Effects from Drug Shortages for Independent Pharmacies and the Potential Role of Drug Buying Groups
Working Paper
2011-01-19
By Dr. Graeme Hunter
Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
Working Paper
2010-02-01
By Dr. Graeme Hunter with Dr. John Vernon and Dr. Joseph Cook
The Future Costs, Risks, and Rewards of Drug Development: The Economics of Pharmacogenomics
Published Article
2009-08-15
By Dr. Graeme Hunter with Dr. John Vernon and Dr. Joseph Cook
1
2
3
4
Next >